|
| Status |
Public on Jun 02, 2023 |
| Title |
Netrin-1 blockade induces tumor growth inhibition and EMT reversion in endometrial cancer. |
| Organisms |
Homo sapiens; Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
Other
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
37532934 |
| |
| Submission date |
Feb 21, 2023 |
| Last update date |
Aug 16, 2023 |
| Contact name |
Nicolas Rama |
| E-mail(s) |
nicolas.rama@lyon.unicancer.fr
|
| Organization name |
CRCL
|
| Street address |
28 rue Laennec
|
| City |
LYON |
| ZIP/Postal code |
69890 |
| Country |
France |
| |
|
| Platforms (2) |
| GPL24247 |
Illumina NovaSeq 6000 (Mus musculus) |
| GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
| Samples (36)
|
|
| This SuperSeries is composed of the following SubSeries:
|
| GSE225687 |
Netrin-1 blockade induces tumor growth inhibition and EMT reversion in endometrial cancer [RNAseqPatient] |
| GSE225688 |
Netrin-1 blockade induces tumor growth inhibition and EMT reversion in endometrial cancer [Mouse_Pten] |
| GSE225689 |
Netrin-1 blockade induces tumor growth inhibition and EMT reversion in endometrial cancer [scRNA-seq] |
| GSE225690 |
Netrin-1 blockade induces tumor growth inhibition and EMT reversion in endometrial cancer [visium data] |
|
| Relations |
| BioProject |
PRJNA937157 |
Less...
More...